Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
maléate de bromphéniramine |
Is a |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine measurement |
Component |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine adverse reaction |
Causative agent (attribute) |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine allergy |
Causative agent (attribute) |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 2mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 10mg/1mL injection 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing brompheniramine maleate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 15mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 10mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 30mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing brompheniramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate + dextromethorphan hydrobromid + phenylpropanolamine hydrochl 2mg/10mg/12.5mg liquid (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+hydrocodone bitartrate+pseudoephedrine hydrochlorid 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing brompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine allergy |
Causative agent (attribute) |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule |
Has basis of strength substance (attribute) |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule |
Has basis of strength substance (attribute) |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
maléate de bromphéniramine |
Is modification of (attribute) |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule |
Has precise active ingredient |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing brompheniramine and guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only brompheniramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine and guaifenesin and hydrocodone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only brompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
Has precise active ingredient |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
Has precise active ingredient |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only brompheniramine and codeine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing brompheniramine and codeine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only brompheniramine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine and dextromethorphan and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only brompheniramine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing brompheniramine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only brompheniramine and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |